Our research focus is in the areas of brain tumors, stroke, epilepsy, movement disorders and trauma to the brain and spinal cord; we join forces with our laboratories and treatment centers to help devise new techniques to make neurosurgery safer and more effective for our patients.
Our clinical programs provide health care professionals the opportunity to observe even rare neurological conditions and the integrative approaches we use to treat the whole patient. For example, the professionals at our Cerebrovascular Center program can manage virtually every condition that affects the blood vessels in the brain and spinal cord. And the Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment and Research offers specialists a peek into world-class, personalized treatment of patients with brain, spine and pituitary tumors.
We place a strong emphasis on learning in the Department of Neurosurgery, which is why we provide an comprehensive seven-year residency program coupled with further educational opportunities such as our Radiosurgery Conferences, Neurosurgery Didactic Teaching Conferences and Neurosurgery Grand Rounds. Each setting fulfills a different academic role, from presenting neuroscience research to studying new and innovative surgical techniques and practices.
Gavin W. Britz, MD, MPH, MBA, FAANS is Professor of Neurosurgery and Chair of the Department of Neurosurgery. He is one of the most experienced cerebrovascular surgeons in the nation and leads a team of surgeons performing some 5000 procedures annually.
US NEWS: NEUROLOGICAL INSTITUTE RANKED NO. 16 IN THE COUNTRY
Houston Methodist Neurological Institute is ranked #16 in U.S. News and World Report’s 2015 rankings for national hospitals in neurology and neurosurgery, we have reached this level of excellence by combining practiced skills with continuous learning and the cutting-edge research from the Houston Methodist Research Institute.
A novel gene therapy using a herpes virus to attack the patient’s tumor
Before he was wheeled into brain surgery, Matt Futer tearfully thanked his parents for a great life. Futer, 44, wasn't likely to die on the operating table, but his fear was understandable. Ten days earlier, he had been diagnosed with a tumor, the type so nasty it kills in an average of 15 months. Read More